نتایج جستجو برای: bruton

تعداد نتایج: 389  

Journal: :Blood 2015
Zachary A Hing Rose Mantel Kyle A Beckwith Daphne Guinn Erich Williams Lisa L Smith Katie Williams Amy J Johnson Amy M Lehman John C Byrd Jennifer A Woyach Rosa Lapalombella

Despite the therapeutic efficacy of ibrutinib in chronic lymphocytic leukemia (CLL), complete responses are infrequent, and acquired resistance to Bruton agammaglobulinemia tyrosine kinase (BTK) inhibition is being observed in an increasing number of patients. Combination regimens that increase frequency of complete remissions, accelerate time to remission, and overcome single agent resistance ...

Journal: :Blood 2012
Yu-Tzu Tai Betty Y Chang Sun-Young Kong Mariateresa Fulciniti Guang Yang Yolanda Calle Yiguo Hu Jianhong Lin Jian-Jun Zhao Antonia Cagnetta Michele Cea Michael A Sellitto Mike Y Zhong Qiuju Wang Chirag Acharya Daniel R Carrasco Joseph J Buggy Laurence Elias Steven P Treon William Matsui Paul Richardson Nikhil C Munshi Kenneth C Anderson

Bruton tyrosine kinase (Btk) has a well-defined role in B-cell development, whereas its expression in osteoclasts (OCs) further suggests a role in osteoclastogenesis. Here we investigated effects of PCI-32765, an oral and selective Btk inhibitor, on osteoclastogenesis as well as on multiple myeloma (MM) growth within the BM microenvironment. PCI-32765 blocked RANKL/M-CSF-induced phosphorylation...

2017
Monika Podhorecka Aneta Goracy Agnieszka Szymczyk Malgorzata Kowal Blanca Ibanez Olga Jankowska-Lecka Arkadiusz Macheta Aleksandra Nowaczynska Elzbieta Drab-Urbanek Sylwia Chocholska Dariusz Jawniak Marek Hus

B cell receptor (BCR) stimulation signal plays an important role in the pathogenesis of chronic lymphocytic leukemia (CLL), and kinase inhibitors directed toward the BCR pathway are now the promising anti-leukemic drugs. Ibrutinib, a Bruton tyrosine kinase inhibitor, demonstrates promising clinical activity in CLL. It is reported that ibrutinib, additionally to directly targeting leukemic cells...

Journal: :Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2015
M Špaček

Chronic lymphocytic leukemia is one of the most common lymphoid malignancies and is characterized by a highly heterogeneous clinical course. Combined regimens, such as fludarabine, cyclophosphamide, and rituximab have led to improvements in survival in younger patients with chronic lymphocytic leukemia and have become the standard of care in fit patients. However, the majority of chronic lympho...

Journal: :Blood 2006
Junling Liu Malinda E Fitzgerald Michael C Berndt Carl W Jackson T Kent Gartner

Botrocetin (bt)-facilitated binding of von Willebrand factor (VWF) to the platelet membrane glycoprotein (GP) Ib-IX-V complex on platelets in suspension initiates a signaling cascade that causes alphaIIbbeta3 activation and platelet aggregation. Previous work has demonstrated that bt/VWF-mediated agglutination activates alphaIIbbeta3 and elicits ATP secretion in a thromboxane A2 (TxA2)-dependen...

Journal: :Journal of immunology 2008
Peter Velázquez Bo Wei Michael McPherson Lesley Marie A Mendoza Sandra L Nguyen Olga Turovskaya Mitchell Kronenberg Tiffany T Huang Matthew Schrage Lynn N Lobato Daisuke Fujiwara Sarah Brewer Moshe Arditi Genhong Cheng R Balfour Sartor Rodney D Newberry Jonathan Braun

B cells are important in mucosal microbial homeostasis through their well-known role in secretory IgA production and their emerging role in mucosal immunoregulation. Several specialized intraintestinal B cell compartments have been characterized, but the nature of conventional B cells in the lamina propria is poorly understood. In this study, we identify a B cell population predominantly compos...

Journal: :Blood 2012
Laurens P Kil Marjolein J W de Bruijn Menno van Nimwegen Odilia B J Corneth Jan Piet van Hamburg Gemma M Dingjan Friedrich Thaiss Guus F Rimmelzwaan Dirk Elewaut Dianne Delsing Pieter Fokko van Loo Rudi W Hendriks

On antigen binding by the B-cell receptor (BCR), B cells up-regulate protein expression of the key downstream signaling molecule Bruton tyrosine kinase (Btk), but the effects of Btk up-regulation on B-cell function are unknown. Here, we show that transgenic mice overexpressing Btk specifically in B cells spontaneously formed germinal centers and manifested increased plasma cell numbers, leading...

Journal: :Blood 2015
Ta-Ming Liu Jennifer A Woyach Yiming Zhong Arletta Lozanski Gerard Lozanski Shuai Dong Ethan Strattan Amy Lehman Xiaoli Zhang Jeffrey A Jones Joseph Flynn Leslie A Andritsos Kami Maddocks Samantha M Jaglowski Kristie A Blum John C Byrd Jason A Dubovsky Amy J Johnson

Ibrutinib has significantly improved the outcome of patients with relapsed chronic lymphocytic leukemia (CLL). Recent reports attribute ibrutinib resistance to acquired mutations in Bruton agammaglobulinemia tyrosine kinase (BTK), the target of ibrutinib, as well as the immediate downstream effector phospholipase C, γ2 (PLCG2). Although the C481S mutation found in BTK has been shown to disable ...

2016
Young-Woo Jeon Seok-Goo Cho

Only 5th decade ago, chronic lymphocytic leukemia (CLL) was only recognized as disease group of presenting features like peripheral lymphocytosis, organomegaly including of splenomegaly. As understanding of disease biology and molecular diagnostic tools are getting improved gradually, characterization of variation in CLL's clinical courses was facilitated, resulting in better risk stratificatio...

Journal: :Blood 2011
Tereza Ormsby Eva Schlecker Janina Ferdin Anja Sibylle Tessarz Pavla Angelisová Afitap Derya Köprülü Michael Borte Klaus Warnatz Ilka Schulze Wilfried Ellmeier Václav Horejsí Adelheid Cerwenka

The triggering receptor expressed on myeloid cells 1 (TREM-1) has been implicated in the production of proinflammatory cytokines and chemokines during bacterial infection and sepsis. For downstream signal transduction, TREM-1 is coupled to the ITAM-containing adaptor DAP12. Here, we demonstrate that Bruton tyrosine kinase (Btk), a member of the Tec kinases, becomes phosphorylated upon TREM-1 tr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید